Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome. Journal Abstract

Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome.

Publication Date: 2024 Oct 15

Full Text Sources

Ovid Technologies, Inc.

PubMed Central (Free)

Silverchair Information Systems (Free)

Authors

Xiaoying Song; Lijiao Xiong; Tianting Guo; Xue Chen; Pinjun Zhang; Xiaoan Zhang; Zhen Liang

Abstract

OBJECTIVE

This study examined the relationship between cystatin C (CysC) levels and all-cause, cardiovascular disease (CVD), and cancer mortality in US metabolic syndrome (MetS) patients.

Source

The Journal of clinical endocrinology and metabolism

Pub Types(s)

Journal Article

Language

English

PubMed ID

38597157